Akumulacija lignana u staničnoj kulturi biljke Linum strictum ssp. strictum L.

Shoot, callus and hairy root cultures of Linum strictum ssp. strictum L. were initiated. The lignan 6-methoxypodophyllotoxin was detected and quantified.Uzgojena je kultura stanica mladica, kalusa i čupavog korijenja biljke Linum strictum ssp. strictum L. U njima je određena količina lignana 6-metoksipodofilotoksina

Production of rare cycloartane saponins from Astragalus thracicus (Griseb) compared to Astragalus membranaceus (Fisch.) Bunge – native and biotechnological sources

The aim of this study is a comparative metabolomic analysis between the endangered species Astragalus membranaceus and endemic species Astragalus thracicus concerning cycloartane saponins. In addition, in vitro shoots, callus, and suspension cultures of A. thracicus were successfully established to conserve the biodiversity of those endemic species and to increase the amount of produced saponins. The comparison was made according to the quantity of cycloartane saponins astragaloside I (1), astragaloside II (2), and astragaloside IV (4) to the reference standards for the same compounds by UHPLC-HRESI-MS analysis. The in vitro root cultures of A. thracicus reached two folds higher amounts of saponins (1.50 mg/g DW (1), 1.01 mg/g DW (2), and 0.91 mg/g DW (3)) than the native root of A. thracicus (1.14 mg/g DW (1) 0.47 mg/g DW (2), 0.40 mg/g DW (3)), and up to six times higher when compared with roots A. membranaceus (0.23 mg/g DW (1), 0.18 mg/g DW (2) and 0.05 mg/g DW (3))

Arylnaphthalene lignans with a focus Linum species: a review on phytochemical, biotechnological and pharmacological potential

Lignans are a large group of dimeric phenylpropanoids with a long and distinguished history of medicinal use in the ancient cultures of many peoples. The two main groups, -aryltetralin and arylnaphthalene lignans, are leading compounds with important pharmacological properties and a wide range of biological activities. While the first group is well studied mainly for the production of podophyllotoxin, for arylnaphthalene lignans, the data on the availability of a sustainable resource for their production is are still insufficient. The Linum genus, comprising approximately 180 species, is notable for its arylnaphthalene lignans production like justicidin B and isojusticidin B. The pharmacological potential of arylnaphthalene lignans includes cytotoxic, antiviral, anti-inflammatory and antiprotozoal effects. The review highlights the use of biotechnology by in vitro cultures for optimising lignan production. Structural elucidation of novel lignans underscores the ongoing diversity and potential discoveries in this botanical domain, providing an important additional information of arylnaphthalene lignans

Supplementary material 1 from: Enchev P, Zarev Y, Ionkova I (2023) Biotechnological approaches for sustainable production of astragaloside I, II and IV from endemic species of Astracantha aitosensis (Ivan.) and Astragalus membranaceus (fisch.) by in vitro cultures. Pharmacia 70(4): 1449-1453. https://doi.org/10.3897/pharmacia.70.e114989

LC/MS spectra of astragalosides I, II and IV within the different fraction

Biotechnological approaches for sustainable production of astragaloside I, II and IV from endemic species of Astracantha aitosensis (Ivan.) and Astragalus membranaceus (fisch.) by in vitro cultures

This study investigates the bioproduction of astragalosides I, II and IV from endemic Astracantha aitosensis (arnacantha) and Astragalus membranaceus species, and the biotechnological methods for increased efficiency. The extracts from established in vitro cultures, including A. aitosensis callus, shoots and roots and A. membranaceus hairy roots, showed higher astragaloside concentrations than native roots. Specifically, in vitro A. aitosensis cultures produced astragaloside I and II at 0.06 and 0.10 mg/g DW, which were absent in native roots. The production of A. membranaceuss hairy roots exceeds 8 to 15 times astragaloside I and II (0.80 and 0.90 mg/g DW) production when compared to native roots (0.10 and 0.05 mg/g DW), and around 3 times high amount related to astragaloside IV. Addressing astragaloside production challenges, this research also reveals biotechnology approaches as an alternative for sustainable production of this rare cycloartane saponins, conserving the natural habitats. A pilot reproducible in vitro cellular platform has been created, and protocol for specific, unconventional induction of the biosynthesis of the desired target compounds, exploiting the enzymatic system of plant cells from the unexplored plant species A. aitosensis has been established. Our findings clearly show the possibility of using in vitro cultures of A. aitosensis and A. membranaceus for biotechnology production of cycloartane type saponins

Biotechnological approaches for sustainable production of astragaloside I, II and IV from endemic species of Astracantha aitosensis (Ivan.) and Astragalus membranaceus (fisch.) by in vitro cultures

This study investigates the bioproduction of astragalosides I, II and IV from endemic Astracantha aitosensis (arnacantha) and Astragalus membranaceus species, and the biotechnological methods for increased efficiency. The extracts from established in vitro cultures, including A. aitosensis callus, shoots and roots and A. membranaceus hairy roots, showed higher astragaloside concentrations than native roots. Specifically, in vitro A. aitosensis cultures produced astragaloside I and II at 0.06 and 0.10 mg/g DW, which were absent in native roots. The production of A. membranaceuss hairy roots exceeds 8 to 15 times astragaloside I and II (0.80 and 0.90 mg/g DW) production when compared to native roots (0.10 and 0.05 mg/g DW), and around 3 times high amount related to astragaloside IV. Addressing astragaloside production challenges, this research also reveals biotechnology approaches as an alternative for sustainable production of this rare cycloartane saponins, conserving the natural habitats. A pilot reproducible in vitro cellular platform has been created, and protocol for specific, unconventional induction of the biosynthesis of the desired target compounds, exploiting the enzymatic system of plant cells from the unexplored plant species A. aitosensis has been established. Our findings clearly show the possibility of using in vitro cultures of A. aitosensis and A. membranaceus for biotechnology production of cycloartane type saponins

The invasive alien species Amorpha fruticosa in Bulgaria and its potential as economically prospective source of valuable essential oil

The high tolerance of various habitat conditions and potent propagation ability of Amorpha fruticosa L. (Fabaceae) promote its aggressive invasive behaviour. The aim of this study is to evaluate 1) several populations of this plant by the potential yield of the fruit, 2) the approximate yield of the essential oils, and 3) composition of the essential oil. The potential yield of fruit is evaluated based on extrapolations of weight and number of fruits per infrutescence, number of infrutescences per plant and number of individuals per population. Steam extraction of the essential oil was performed and GS/MS analysis of the composition of the essential oil. The populations on our key plots are big enough for harvesting with fruit/infrutescence 152 ±15 (n = 20) and infrutescences/shrub 436 ±157 (n = 20). The yield is 0.83 ml/100g. We identified 22 components with major constituents caryophyllene (17.64%) α-guaiene (14.70%), naphthalene (6.75%), γ-muurolene + (5.98%)

Biotransformation of quercetin, kaempferol and apigenin to monoglycosylated derivatives by in vitro suspension cultures of Astragalus vesicarius ssp. carniolicus

Biotransformation of exogenous substrates quercetin, kaempferol and apigenin by suspension cultures of Astragalus vesicarius ssp. carniolicus to their monoglycosylated derivatives was performed. The maximal enzymatic potential of cells of A. vesicarius ssp. carniolicus was evaluated by different concentrations of substrate exposure. According to quantitative ultra-high performance liquid chromatography-high resolution electrospray ionization mass spectrometry (UHPLC-HR-ESI-MS) analysis, the highest concentration of kaempferol O-glycoside (14.88 nmol/g dry weight, DW), apigenin O-glycoside (10.55 nmol/g DW) and quercetin O-glycoside (150.83 nmol/g DW) was achieved, when suspension cultures were treated with 4 mg/mL kaempferol, 4 mg/mL apigenin and 3 mg/mL quercetin, respectively. The glycosidic products of biotransformation were not detected in the untreated control

Invasive alien species – potential cheap resources of plant substances for medicinal use

Some alien species demonstrate rather invasive behaviour. They have high tolerance of various habitat conditions and potent propagation ability. They not only over-compete the local vegetation but suppress the seed development of the native plants. In the newly invaded habitats they might not have suitable herbivores to control their populations. The only effective enemy might be Homo sapiens. Humans are known with their destructive power once an object has become significant for industrial utilization. The aim of this study is to review research data and reveal the potential of Ambrosia artemisiifolia L., Erigeron canadensis L., Xanthium strumarium L. and Dittrichia graveolens (L.) W. Greuter, as cheap sources of compounds with valuable pharmacological activities. Ethnobotanical data from their habitats reveal promising medicinal potential. A growing body of sci- entific literature points to their therapeutic properties. Valuable chemical constituents of these alien invasive species are sesquiterpene lactones, essential oils etc. They possess different activities such as anticancer activity, as well as antitussive, antifungal, antiinflammatory, antinociceptive, hypoglycemic, antimitotic, antioxidant, antitrypanosomal, CNS depressant activity, diuretic effects, contact dermatitis, insecticidal and herbicidal activities, hepatoprotective and hypolipemic activities etc. Due to the fact that these are aggressive invasive species, they can provide abundant and cheap resources reach of plant chemical constituents which can be utilized for therapeutic purposes. Additionally, exploitation of the biomass for medicinal use might contribute to relieving the destructive impact of these species on natural habitats